Dimensional Fund Advisors LP boosted its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 1.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 695,170 shares of the company’s stock after buying an additional 9,293 shares during the period. Dimensional Fund Advisors LP owned about 2.78% of USANA Health Sciences worth $40,042,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. First Trust Advisors LP raised its position in USANA Health Sciences by 104.3% in the first quarter. First Trust Advisors LP now owns 25,069 shares of the company’s stock valued at $1,444,000 after buying an additional 12,800 shares during the period. Wells Fargo & Company MN raised its position in USANA Health Sciences by 70.8% in the first quarter. Wells Fargo & Company MN now owns 31,480 shares of the company’s stock valued at $1,814,000 after buying an additional 13,044 shares during the period. Old Mutual Global Investors UK Ltd. raised its position in USANA Health Sciences by 2.3% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 184,849 shares of the company’s stock valued at $10,647,000 after buying an additional 4,217 shares during the period. Russell Investments Group Ltd. raised its position in USANA Health Sciences by 11.8% in the first quarter. Russell Investments Group Ltd. now owns 27,619 shares of the company’s stock valued at $1,591,000 after buying an additional 2,926 shares during the period. Finally, Janney Montgomery Scott LLC raised its position in USANA Health Sciences by 37.7% in the first quarter. Janney Montgomery Scott LLC now owns 6,619 shares of the company’s stock valued at $381,000 after buying an additional 1,813 shares during the period. Hedge funds and other institutional investors own 44.21% of the company’s stock.

USANA Health Sciences, Inc. (USNA) opened at 63.40 on Monday. USANA Health Sciences, Inc. has a 1-year low of $52.55 and a 1-year high of $75.00. The company’s 50 day moving average is $64.31 and its 200 day moving average is $60.95. The company has a market cap of $1.55 billion, a price-to-earnings ratio of 16.01 and a beta of 1.13.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, May 2nd. The company reported $0.91 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.92 by $0.01. USANA Health Sciences had a return on equity of 31.84% and a net margin of 9.71%. The firm had revenue of $255.32 million during the quarter. Equities research analysts forecast that USANA Health Sciences, Inc. will post $3.95 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “USANA Health Sciences, Inc. (NYSE:USNA) Stake Raised by Dimensional Fund Advisors LP” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/07/24/usana-health-sciences-inc-nyseusna-stake-raised-by-dimensional-fund-advisors-lp.html.

Several research analysts recently commented on the stock. BidaskClub upgraded shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Tuesday, June 13th. Zacks Investment Research upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Wednesday, April 12th. Finally, Pivotal Research reiterated a “hold” rating and set a $55.00 price objective (down previously from $75.00) on shares of USANA Health Sciences in a research note on Monday, May 1st.

In related news, Director Myron W. Wentz sold 40,000 shares of USANA Health Sciences stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $56.39, for a total value of $2,255,600.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Paul A. Jones sold 9,851 shares of USANA Health Sciences stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $64.50, for a total transaction of $635,389.50. Following the completion of the transaction, the insider now owns 6,020 shares of the company’s stock, valued at approximately $388,290. The disclosure for this sale can be found here. Insiders sold 134,735 shares of company stock valued at $8,371,021 in the last quarter. 53.20% of the stock is owned by insiders.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.